Experience

Davis Polk advised the dealer managers in connection with Empresa Eléctrica Angamos SpA’s cash tender offer for up to the outstanding $388 million aggregate principal amount of its 4.875%…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of 2.807% senior notes due 2050 by…

Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its American depositary shares for up to a maximum offering price of …

Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Fresnillo plc of 4.250% senior notes due 2050 in the aggregate amount of $850…

Davis Polk advised Boqii Holding Limited on its SEC-registered initial public offering of 7,000,000 American depositary shares. Each ADS represents 0.75 Class A ordinary share of Boqii…

Davis Polk advised the underwriters in connection with an offering by Kemper Corporation of $400 million aggregate principal amount of its 2.400% senior notes due 2030. Kemper…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €6.25 billion aggregate principal amount of notes by Medtronic Global…

 Davis Polk advised ADC Therapeutics SA on its SEC-registered offering of 6,000,000 common shares for total gross proceeds of $204 million. ADC Therapeutics is listed on the New York…

Davis Polk advised Kingsoft Cloud Holdings Limited and certain selling shareholders on its approximately $509 million SEC-registered follow-on public offering of 16,421,576 American…

Davis Polk advised Zai Lab Limited in connection with its secondary listing and initial public offering on the Hong Kong Stock Exchange. Zai Lab is the first company listed under both…